Literature DB >> 9356059

Direct induction of acute lung and myocardial dysfunction by liver ischemia and reperfusion.

A A Weinbroum1, E Hochhauser, V Rudick, Y Kluger, P Sorkine, E Karchevsky, E Graf, P Boher, R Flaishon, D Fjodorov, D Niv, B A Vidne.   

Abstract

OBJECTIVES: To investigate whether liver ischemia and reperfusion (IR) directly affect functions of remote organs.
BACKGROUND: Cardiovascular and respiratory dysfunction follows hemorrhage, spinal shock, or trauma as a result of no-flow-reflow phenomena. Hepatic IR induces remote organ damage probably by xanthine oxidase and oxygen species.
MATERIALS AND METHODS: Isolated rat livers, lungs, and hearts were perfused with Krebs-Henseleit solutions. After stabilization, livers were either perfused or made ischemic. Then, livers and hearts or livers and lungs were reperfused in series, and the liver was disconnected and the second organ continued to perfuse with the accumulated effluents.
MEASUREMENTS AND MAIN RESULTS: Ischemic and reperfused liver effluent contained high lactate dehydrogenase and uric acid concentrations compared with controls; xanthine oxidase increased 60 to 100 times. Ischemic and reperfused lung peak inspiratory pressure almost doubled; airway static compliance halved; myocardial contractility decreased to 70% of baseline; wet weight-to-dry weight ratios of lungs and livers increased.
CONCLUSION: Ischemic and reperfused liver can directly induce myocardial and pulmonary dysfunction, presumably by oxidant-induced injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356059     DOI: 10.1097/00005373-199710000-00011

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  16 in total

1.  Methylene blue attenuates pancreas ischemia-reperfusion (IR)-induced lung injury: a dose response study in a rat model.

Authors:  Avi A Weinbroum
Journal:  J Gastrointest Surg       Date:  2009-07-01       Impact factor: 3.452

2.  Naloxone pretreatment prevents kidney injury after liver ischemia reperfusion injury.

Authors:  Mohammad Ashrafzadeh Takhtfooladi; Mehran Shahzamani; Ahmad Asghari; Aris Fakouri
Journal:  Int Urol Nephrol       Date:  2016-04-07       Impact factor: 2.370

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

4.  Effects of vasoactive substances released from ischemic reperfused liver on the isolated rat heart.

Authors:  E Hochhauser; I Alterman; A Weinbroum; Y Barak; D Harell; A Raz; A Erman; B Vidne
Journal:  Exp Clin Cardiol       Date:  2001

5.  HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat.

Authors:  Anding Liu; Olaf Dirsch; Haoshu Fang; Jian Sun; Hao Jin; Wei Dong; Uta Dahmen
Journal:  Histochem Cell Biol       Date:  2011-03-24       Impact factor: 4.304

6.  Oxidants as important determinants of renal apoptosis during pneumoperitoneum: a study in an isolated perfused rat kidney model.

Authors:  Wisam Khoury; Avi A Weinbroum
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

7.  Renal oxidative stress following CO2 pneumoperitoneum-like conditions.

Authors:  Wisam Khoury; Letizia Schreiber; Amir Szold; Joseph M Klausner; Avi A Wienbroum
Journal:  Surg Endosc       Date:  2008-07-16       Impact factor: 4.584

8.  Mannitol prevents acute lung injury after pancreas ischemia-reperfusion: a dose-response, ex vivo study.

Authors:  Avi A Weinbroum
Journal:  Lung       Date:  2009-06-17       Impact factor: 2.584

9.  Remote renal injury following partial hepatic ischemia/reperfusion injury in rats.

Authors:  Matthias Behrends; Ryutaro Hirose; Yeon Ho Park; Vivian Tan; Kim Dang; Fengyung Xu; Se Hun Park; Claus U Niemann
Journal:  J Gastrointest Surg       Date:  2007-08-14       Impact factor: 3.452

10.  Early myocardial injury is an integral component of experimental acute liver failure - a study in two porcine models.

Authors:  Nikolaos Papoutsidakis; Nikolaos Arkadopoulos; Vassilios Smyrniotis; Helen Tzanatos; Konstantinos Kalimeris; Konstantinos Nastos; George Defterevos; Agathi Pafiti; Georgia Kostopanagiotou
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.